🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excited to share our paper in NatureRevClinOncol! 📚🎉 We reviewed the most common long-term and late or delayed adverse events associated w chemotherapy & other anticancer treatments Huge thanks to Nicole Kuderer, MD, MS, FASCO 🌎🇺🇸🇪🇺🇺🇦🌏 Gary Lyman 🇺🇸🇪🇺🇺🇦💛💙 Maryam Lustberg MD, MPH, FASCO Aakash Desai, MD, MPH nature.com/articles/s4157…

The super Università di Genova Ospedale San Martino Genova team rocking at #ASCO24 🤩🔥❤️🔝💪 OncoAlert Lucia Del Mastro Marta Perachino Maria Maddalena Latocca ChiaraMolinelli Luca Arecco, MD Marco Tagliamento Francesca Poggio Silvia Puglisi

I couldn’t be more proud to be part of this incredible group of colleagues, scientists, and friends. Super Università di Genova Ospedale San Martino Genova group at #ASCO24 ! 🇮🇹 Lucia Del Mastro Matteo Lambertini, MD PhD Francesca Poggio Marco Tagliamento Maria Maddalena Latocca ChiaraMolinelli Marta Perachino Silvia Puglisi

Go Luca Arecco, MD go !!!!! Super proud of our Università di Genova Ospedale San Martino Genova young team !!! OncoAlert #ASCO24

Glad to represent Ospedale San Martino Genova at the general assembly and scientific conference of Organisation of European Cancer Institutes in Helsinki 🇫🇮 during the 2024 Oncology Days, the annual event of the Organisation of European Cancer Institutes. 🇪🇺 OncoAlert

Lung cancer is, in part, a hereditary disease. Excited to share our perspective on the incorporation of germline testing in patients with lung cancer Triparna Sen (Sen-Lab) Fred R. Hirsch Kostas Syrigos Hellenic Association of Lung Cancer (HeALC) ΕΛΕΚΑΠ The Lancet Respiratory Medicine thelancet.com/journals/lanre….

Key papers oncologia Pubblicazione n. 62 LUNG A cura di Marco Tagliamento (GE), Lucrezia Barcellini (GE) Per visualizzare la pubblicazione: keypapers.it/keypapers-62

In #CancerTreatmentReviews we addressed the use of #ctDNA in localized #NSCLC, including: 🧪Techniques for ctDNA detection 🩸Current main applications 🧬Future directions Open access: doi.org/10.1016/j.ctrv… Arianna Marinello, MD Filippo Dall'Olio Benjamin Besse Jordi Remon OncoAlert

Congrats to Roberta Grassi and Marco Tagliamento for their outstanding talks 🫁🔬at the AIOM giovani congress in Florence! 🎉 Great job to everyone who presented in their sessions⭐️Looking forward to more insightful discussions and collaborations!

Congrats to Francesca Poggio for this publication in ESMO Open. Efficacy of adjuvant chemotherapy schedules for breast cancer according to BMI within the randomized GIM2 trial. Link: doi.org/10.1016/j.esmo… Lucia Del Mastro Matteo Lambertini, MD PhD Eva Blondeaux Ospedale San Martino Genova OncoAlert #bcsm

While amylase & lipase elevation often seen in trials of targeted agents, actual clinical pancreatitis is uncommon. In this retrospective report Clinical Lung Cancer from Drs. Meyer May-Lucie Mihaela Aldea and team, incidence of clinical pancreatitis was .08%! clinical-lung-cancer.com/article/S1525-…

Stephen V Liu, MD Clinical Lung Cancer Mihaela Aldea Thank you! And thanks to Natalie Décosterd Louis Gros d.planchard Fabrice Barlesi Arianna Marinello, MD Marco Tagliamento Benjamin Besse Jordi Remon and David Combarel!

Starting the morning with the IASLC Educational committee at #WCLC24 Great discussions and plans. Terrific group! Pranshu Mohindra Hidehito HORINOUCHI Paula A. Ugalde Clarissa Baldotto Francesco Alessandro Russo Marco Tagliamento Rami Manochakian MD, FASCO 🇺🇸🇸🇾CancerEducation Mihaela Aldea Jyoti D Patel

Early-morning meeting of the IASLC Education Committee today at the #WCLC24! Planning a lot of activities for the upcoming months

Presidential #WCLC24. Neoadjuvant CT+IT vs perioperative IT. We still don't know what the best strategy is after this analysis. We are comparing two selected populations: patients who had surgery in CM 816 (83%) and those who had surgery+adjuvant IT in CM 77T (62% !!). IASLC

Join us today at the #WCLC24 Educational Session “Immunotherapy: Moving Beyond PD-1/PD-L1 and CTLA4” Thrilled to take part! 📍 Room 30DE ⏱ 2.00 PM to 3.15 PM IASLC Noemi Reguart OncoAlert #LCSM

Innate immunity: unpredictable complex and often neglected in cancer immunotherapy. Great presentation from Marco Tagliamento #WCLC2024

San Diego #WCLC24 Biagio Ricciuti, MD PhD Mihaela Aldea Marco Tagliamento